• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Thermo Fisher Scientific

10 leading pharma executives you need to know

April 25, 2022 By Brian Buntz

Given the complexity of the pharmaceutical business, it can be challenging to gauge the performance of any chief executive in the space. That said, CEOs’ annualized return over tenure as CEO over their term can hint at performance. In addition, rating sites like Glassdoor also indicate CEOs’ popularity. Here, we parsed a range of metrics, […]

Filed Under: Blog, Business/Financial News, Featured, News Well, Pharmaceutical Tagged With: AbbVie, Argenx, Eli Lilly, Evotec, Genmab, leadership, Novo Nordisk, Pfizer, Pharma 50, pharma execs, Sartorius Stedim Biotech, Thermo Fisher Scientific, West Pharmaceutical Services

Thermo Fisher launches PCR testing platform that detects COVID-19 pathogens in the air

February 7, 2022 By Sean Whooley

Thermo Fisher Scientific (NYSE:TMO) announced today that it launched a new rapid environmental COVID-19 diagnostic platform. Waltham, Massachusetts-based Thermo Fisher designed its Renvo rapid in-air pathogen PCR test for detecting the virus on air samples collected through the company’s Thermo Scientific AerosolSense Sampler. According to a news release, the company designed the test for environmental […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics, News Well Tagged With: coronavirus, COVID-19, Thermo Fisher Scientific

Thermo Fisher Scientific ticks up on Street-beating Q4 results

February 2, 2022 By Danielle Kirsh

Thermo Fisher Scientific (NYSE:TMO) today posted fourth-quarter results that beat the overall consensus on Wall Street. The Waltham, Massachusetts–based laboratory supply company reported profits of $1.7 billion, or $4.17 per share, on sales of $10.7 billion for the three months ended Dec. 31, 2021, for a bottom-line loss of -33.6% on sales growth of 1.42% […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Thermo Fisher Scientific

OncoCyte announces development and marketing agreement with Thermo Fisher Scientific

January 19, 2022 By Sean Whooley

Oncocyte (NSDQ:OCX) announced yesterday that it entered into a development and co-marketing agreement with Thermo Fisher Scientific (NYSE:TMO). The development and co-marketing agreement covers two distributed in vitro diagnostic (IVD) assays on Thermo Fisher’s Ion Torrent Genexus system and grants Oncocyte the rights to develop future companion diagnostics on the Genexus system. Under the collaboration […]

Filed Under: Business/Financial News, Diagnostics, Genomics/Molecular Diagnostics Tagged With: OncoCyte, Thermo Fisher Scientific

Thermo Fisher Scientific completes $1.85B Peprotech acquisition

January 5, 2022 By Sean Whooley

Thermo Fisher Scientific (NYSE:TMO) announced today that it completed its acquisition of PeproTech for approximately $1.85 billion. Cranbury, New Jersey–based PeproTech develops recombinant proteins, including cytokines and growth factors, for use in the development and manufacturing of cell and gene therapies, as well as in other broader cell culture applications. Get the full story at our […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, News Well, Pharmaceutical Tagged With: PeproTech, Thermo Fisher Scientific

Thermo Fisher completes $17.4B acquisition of PPD

December 8, 2021 By Sean Whooley

Thermo Fisher Scientific (NYSE:TMO) announced today that it completed its previously announced $17.4 billion acquisition of PPD. Waltham, Massachusetts-based Thermo Fisher announced in April that it would acquire the company that provides clinical research services to the biopharma and biotech industry. PPD ceased trading on the Nasdaq prior to opening today and will become part of […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Pharmaceutical Tagged With: PPD Inc., Thermo Fisher Scientific

Baxter, 3M, Abbott near the top of Newsweek’s most responsible companies list

December 3, 2021 By Sean Whooley

Several medtech, healthcare and life sciences companies, including big names like Abbott (NYSE:ABT), 3M (NYSE:MMM) and Baxter (NYSE:BAX), are among the 500 “most responsible,” according to Newsweek. The outlet published its “America’s Most Responsible Companies 2022” list, marking the third installment of the compilation (in partnership with Statista), this time expanded to include 500 of […]

Filed Under: Business/Financial News, Featured, News Well Tagged With: 3m, Abbott, Amerisource Bergen, Avanos Medical (formerly Halyard Health), Baxter, BD, Biogen, Boston Scientific, Cantel Medical Corp., Cardinal Health, Edwards Lifesciences, Gilead Sciences, Henry Schein, Hillrom, Hologic, Illumina Inc., Insulet, LabCorp, Merck, Pfizer, Quest Diagnostics Inc., ResMed, Thermo Fisher Scientific, Varex Imaging, Varian Medical Systems

COVID-19 test makers say their products also detect Omicron

November 30, 2021 By Chris Newmarker

Abbott, BD, Hologic, PerkinElmer and Thermo Fisher are reassuring the public that their COVID-19 tests detect the Omicron variant. Discovered last week in South Africa, the new variant has enough mutations that it has raised concerns worldwide — even though it is still unknown for sure whether the mutations cause greater transmissibility or vaccine evasion. […]

Filed Under: Diagnostics, Featured, News Well Tagged With: Abbott, BD, coronavirus, COVID-19, Hologic, PerkinElmer Inc., Thermo Fisher Scientific

Thermo Fisher says TaqPath tests can detect Omicron variant of COVID-19

November 29, 2021 By Sean Whooley

Thermo Fisher Scientific (NYSE:TMO) said today that its TaqPath diagnostic kit can detect the emerging Omicron variant of COVID-19. Waltham, Massachusetts-based Thermo Fisher’s polymerase chain reaction (PCR) TaqPath COVID-19 Combo Kit and TaqPath COVID-19 CE-IVD RT-PCR Kit, which test for the presence of SARS-CoV-2 (the virus causing COVID-19), offer accurate results for samples with the […]

Filed Under: Diagnostics, Featured, Genomics/Molecular Diagnostics Tagged With: coronavirus, COVID-19, Thermo Fisher Scientific

Medtech M&A: The industry’s biggest mergers and acquisitions of 2021

November 5, 2021 By Sean Whooley

Across 2021, medtech has seen a wide range of mergers and acquisitions covering several areas of devices, pharmaceuticals and more. Some have gone off without a hitch, while others fell into serious scrutiny as mouthwatering financial figures were revealed and major technologies were acquired. Here are the 10 biggest mergers and acquisitions in medtech in […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Wall Street Beat Tagged With: Baxter, Boston Scientific, GE Healthcare, Grail, Hillrom, Illumina Inc., Medtronic, PerkinElmer Inc., Philips, Roche, Sanofi, Siemens Healthineers, Thermo Fisher Scientific, Varian Medical Systems, Vectura

Thermo Fisher Scientific ticks up on Street-beating Q3 results

October 27, 2021 By Danielle Kirsh

Thermo Fisher Scientific (NYSE:TMO) today posted third-quarter results that beat the overall consensus on Wall Street. The Waltham, Massachusetts–based laboratory supply company reported profits of $1.9 billion, or $4.79 per share, on sales of $9.3 billion for the three months ended October 2, for a bottom-line loss of -1.6% on sales growth of 9.49% compared with […]

Filed Under: Lab Instruments & Supplies, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Thermo Fisher Scientific

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 11
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS